Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
Mobile Game Revenue Steadily Recovering, Report Says
Henlius Biotech Raises $410 Million in Hong Kong IPO
Chinese Smartphone-Maker, Big in Africa, Prices IPO Far Above Apple
LATEST
China Expected to Have First Self-Designed DRAM Chip by Year End
Chinese Gaming Giant NetEase to Raise More Pigs
AB InBev Asian IPO Price Polling Below Midpoint of Range, Again
iPhone 11 Released in China to Mixed Reception From Shoppers
Pony Ma Steps Down as Tencent Credit’s Legal Representative
Local Emissions-Cutting Projects Could Help China Surpass International Commitments: Report
Short-Term Reference Rate for Loan Pricing Edges Down
Tencent Offers Open-Source System for IoT Innovation
Chinese Smartphone-Maker, Big in Africa, Prices IPO Far Above Apple
Dajia Insurance Launches Online Shop
World’s Highest Grid Project Takes Shape on ‘Roof of the World’
Battery Giant CATL in $1.4 Billion Fund-Raising Plan
Alibaba Recruits Big-Hitters for AI Research Labs
Zhejiang Regulators May Struggle to Implement Consumer Loan Rules
Is This Chinese Local Government Using a Journalist’s Trial to Quash Dissent?
ABB Bulks Up With Huawei on Industrial Cloud
China Biologic Receives $4.6 Billion Buyout Offer
Henlius Biotech Raises $410 Million in Hong Kong IPO
Mobile Game Revenue Steadily Recovering, Report Says
China’s Cybersecurity Industry Expected to Grow 23% to $8.9 Billion
BGI Genomics to Invest in Qingdao Medical Park

By Tang Ziyi / Jun 26, 2019 06:08 PM / Business & Tech

Photo: IC Photo

Photo: IC Photo

Chinese genomics giant BGI Genomics will spend 470 million yuan ($68.3 million) on establishing an industrial park in the eastern port city of Qingdao, Shandong province, the company said Tuesday.

The planned medical park will focus on researching and developing tests for conditions including congenital diseases and tumors, according to the statement.

The Qingdao medical park is the latest in a wave of genetics industrial parks that are sweeping China, as the country hopes to dominate the burgeoning industry. The controversial announcement last year that the world’s first genetically altered babies had been born in China drew attention to the southern Chinese city of Shenzhen, where the scientist who claimed to have altered the babies’ DNA — He Jiankui — had worked. Shenzhen is home to two of China’s biggest genetics industrial parks, including one jointly financed by BGI.

Related: Genome Sequencing Giant BGI's Fundraising Flops

A previous version of this story inaccurately described He Jiankui's connection to a BGI-funded park in Shenzhen.

Contact reporter Tang Ziyi (ziyitang@caixin.com)

Share this article
Open WeChat and scan the QR code